Not medical advice. Talk to your provider before using any peptide.
Full disclaimerFour peptides, four aging mechanisms, 30 days. Ben Pakulski targets mitochondria with SS-31 (10mg daily), telomeres with Epithalon (5mg, 5x/week), immune function with TA-1 (1.5mg daily), and senescent cells with FOXO4-DRI (10mg EOD for 2 weeks). The FOXO4-DRI dose is 3.3x the standard aggressive tier. Budget $500-1,200 and consider starting with 1-2 peptides rather than all four simultaneously.
Counted from this protocol's own dose schedule, assuming 5mg, 10mg, 5mg, 5mg vials and no vial shared between two doses. Some doses are larger than one vial and draw from more than one. Not purchasing or medical advice.
Most users report no noticeable benefits. Injection site reactions are the dominant early experience.
Subtle energy improvements reported by some users. Better exercise tolerance and modest reduction in post-workout fatigue. Injection site reactions begin to moderate with site rotation.
More consistent daily energy, improved exercise performance, better recovery. Some report cognitive clarity. Peak eosinophilia around day 90.
For educational purposes only. Not medical advice. Consult a healthcare provider before starting any peptide protocol.